Applied Molecular Transport Inc.
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY22 | FY21 | FY20 | FY19 | |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Operating income | −$127.2M | −$100.8M | −$66.7M | −$28.3M |
| Net income | −$126.3M | −$100.3M | −$66.6M | −$28.0M |
| Total assets | $107.4M | $214.0M | $140.2M | $38.5M |
| Total liabilities | $46.6M | $50.5M | $8.5M | $4.6M |
| Equity | $60.8M | $163.6M | $131.7M | −$71.7M |
| EPS (diluted) | $-3.25 | $-2.67 | $-2.91 | — |
| Shares out. | 38.7M | 35.2M | 35.1M | 7.4M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2022- Operating margin
- —
- Net margin
- —
- Return on equity
- −207.6%
- Return on assets
- −117.6%
- Return on capital (ROCE)
- −137.7%
- Liabilities / assets
- 43.4%
- Debt / equity
- 0.77×
- Book value / share
- $1.57
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2022- Altman Z″ (distress)
- -14.70distress
- Accruals / assets
- −30.2%clean
- Piotroski F-Score
- 1/7weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 1 warning● 2 good- Altman Z″ in the distress zone
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsDec 27, 2023
- Shareholder voteDec 26, 2023
- Other material eventDec 15, 2023
- Results of operationsNov 9, 2023
- Other material eventOct 25, 2023
- Regulation FD disclosureSep 27, 2023
- Entered a material agreement · Director / officer change · Regulation FD disclosureSep 21, 2023
- Delisting / listing-standard noticeAug 14, 2023
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13G/AFeb 14, 2024
- 15-12GFORM 15-12GJan 9, 2024
- SC 13D/AEPIQ13D1Jan 5, 2024
- EFFECTJan 2, 2024
- POSASRFORM POSASRJan 2, 2024
- POS AMFORM POS AMJan 2, 2024
- S-8 POSFORM S-8 POSJan 2, 2024
- S-8 POSFORM S-8 POSJan 2, 2024
- S-8 POSFORM S-8 POSJan 2, 2024
- 4Dec 29, 2023
- 4FORM 4 SUBMISSIONDec 28, 2023
- 4FORM 4 SUBMISSIONDec 28, 2023
- 4FORM 4 SUBMISSIONDec 28, 2023
- 4FORM 4 SUBMISSIONDec 28, 2023
- 4FORM 4 SUBMISSIONDec 28, 2023
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.